ETESEVIMAB

UNII:	N7Q9NLF11I
Formula:
Preferred Substance Name:	ETESEVIMAB

2423948-94-9
ANTI-SARS-COV-2 ANTIBODY JS016
CB6
CB-6
ETESEVIMAB [INN]
ETESEVIMAB [USAN]
ETESEVIMAB [WHO-DD]
IMMUNOGLOBULIN G1 (236-ALANINE,237-ALANINE), ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN RECEPTOR-BINDING DOMAIN) (HUMAN MONOCLONAL JS016 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL JS016 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1 (236-ALANINE,237-ALANINE), ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN) (HUMAN MONOCLONAL LY3832479 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL LY3832479 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1*03-KAPPA, ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN (PEPLOMER PROTEIN, E2))HUMAN MONOCLONAL ANTIBODY.GAMMA.1 HEAVY CHAIN (1-449) (HOMO SAPIENS VH (IGHV3-66*01 (97%) (IGHD)-IGHJ4*01 (93%)) (8.7.13) (1-119)-HOMO SAPIENS IGHG1*03 (CH2(L4>A(236),L5>A(237))) (120-449)) (222-216')-DISULFIDE WITH .KAPPA. LIGHT CHAIN (1'-216') (HOMO SAPIENS V-KAPPA (IGKV1-39*01 (98%) IGKJ2*01)(6.3.11) (1'-109')-HOMO SAPIENS IGKC*01 (110'-216')), DIMER (228-228'':231-231'')-BISDISULFIDE
JS016
JS-016
LY COV016
LY3832479
LY-3832479
LY-COV016
NP005
NP-005

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

ETESEVIMAB

Synonyms and Mappings

Resources